Interleukin-4 receptor -3223C→T polymorphism is associated with increased gastric adenocarcinoma risk

Canadian Journal of Gastroenterology

Volumn 26, Issue 8, 2012, Pages 532-536

  Burada, Florin ^a   Angelescu, Cristina ^a   Mitrut, Paul ^a   Ciurea, Tudorel ^a   Cruce, Mihai ^a   Saftoiu, Adrian ^a   Ioana, Mihai ^a  

^a UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

Cytokine; Gastric cancer; Genetic predisposition; Promoter polymorphism

Indexed keywords

ADENINE; CYTOSINE; GUANOSINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 8; THYMINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PROBE; PIACENZIAN; POPULATION STRUCTURE; PRIORITY JOURNAL; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; STOMACH ADENOCARCINOMA;

EID: 84865314121     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2012/804173     Document Type: Article

References (37)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
2. Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005;21:32-8.
3. Gonzalez CA, Sala N, Capella G. Genetic susceptibility and gastric cancer risk. Int J Cancer 2002;100:249-60.
4. Correa P. Helicobacter pylori and gastric cancer: State of the art. Cancer Epidemiol Biomarkers Prev 1996;5:477-81.
5. Lehmann FS, Terracciano L, Carena I, et al. In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis. Am J Physiol Gastrointest Liver Physiol 2002;283:G481-8.
6. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-72.
7. El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000;404:398-402.
8. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
9. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006;19:449-90.
10. Sporea I, Popescu A, van Blankenstein M, Sirli R, Focsea M, Danila M. The prevalence of Helicobacter pylori infection in western Romania. Rom J Gastroenterol 2003;12:15-8.
11. Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
12. Hackstein H, Hecker M, Kruse S, et al. A novel polymorphism in the 5? promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001;53:264-9.
13. Kato I, Canzian F, Franceschi S, et al. Genetic polymorphisms in anti-inflammatory cytokine signaling and the prevalence of gastric precancerous lesions in Venezuela. Cancer Causes Control 2006;17:1183-91.
14. Crusius JB, Canzian F, Capella G, et al. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST). Ann Oncol 2008;19:1894-902.
15. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997;24:1-8.
16. Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004;53:1082-9.
17. Lu W, Pan K, Zhang L, Lin D, Miao X, You W. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005;26:631-6.
18. Sugimoto M, Furuta T, Shirai N, et al. Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 2007;22:1443-9.
19. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003;124:1193-201.
20. Zambon CF, Basso D, Navaglia F, et al. Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: Interactions influence outcome. Cytokine 2005;29:141-52.
21. Garcia-Gonzalez MA, Lanas A, Quintero E, et al. Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: A nationwide multicenter study in Spain. Am J Gastroenterol 2007;102:1878-92.
22. Savage SA, Abnet CC, Haque K, et al. Polymorphisms in interleukin -2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk chinese population. Cancer Epidemiol Biomarkers Prev 2004;13:1547-9.
23. Kondo S, Shinomura Y, Kanayama S, et al. Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 1994;267:G966-71.
24. Hall SK, Perregaux DG, Gabel CA, et al. Correlation of polymorphic variation in the promoter region of the interleukin-1 beta gene with secretion of interleukin-1 beta protein. Arthritis Rheum 2004;50:1976-83.
25. Machado JC, Pharoah P, Sousa S, et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001;121:823-9.
26. Zhang WH, Wang XL, Zhou J, An LZ, Xie XD. Association of interleukin-1B (IL-1B) gene polymorphisms with risk of gastric cancer in Chinese population. Cytokine 2005;30:378-81.
27. Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005;114:237-41.
28. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001;36:696-9.
29. Canedo P, Duraes C, Pereira F, et al. Tumor necrosis factor alpha extended haplotypes and risk of gastric carcinoma. Cancer Epidemiol Biomarkers Prev 2008;17:2416-20.
30. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
31. Machado JC, Figueiredo C, Canedo P, et al. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003;125:364-71.
32. Lee JY, Kim HY, Kim KH, et al. Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett 2005;225:207-14.
33. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-7.
34. Lee WP, Tai DI, Lan KH, et al. The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in the Chinese population. Clin Cancer Res 2005;11:6431-41.
35. Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev 2005;14:2487-93.
36. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 2006;17:117-25.
37. Savage SA, Hou L, Lissowska J, et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev 2006;15:589-91.